Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul;130(7):409-19.
doi: 10.1016/j.mad.2009.04.002. Epub 2009 May 3.

Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response

Affiliations

Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response

Christina Batsi et al. Mech Ageing Dev. 2009 Jul.

Abstract

Normal cells divide for a limited number of generations, after which they enter a state of irreversible growth arrest termed replicative senescence. While replicative senescence is due to telomere erosion, normal human fibroblasts can undergo stress-induced senescence in response to oncogene activation, termed oncogene-induced senescence (OIS). Both, replicative and OIS, initiate a DNA damage checkpoint response (DDR) resulting in the activation of the p53-p21(Cip1/Waf1) pathway. However, while the nuclear factor-kappaB (NF-kappaB) signaling pathway has been implicated in DDR, its role in OIS has not been investigated. Here, we show that oncogenic Ha-RasV12 promoted premature senescence of IMR-90 normal human diploid fibroblasts by activating DDR, hence verifying the classical model of OIS. However, enforced expression of a constitutively active IKKbeta T-loop mutant protein (IKKbetaca), significantly delayed OIS of IMR-90 cells by suppressing Ha-RasV12 instigated DDR. Thus, our experiments have uncovered an important selective advantage in chronically activating canonical NF-kappaB signaling to overcome the anti-proliferative OIS response of normal primary human fibroblasts.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Expression of NF-κB signaling pathway components during replicative senescence of IMR-90. (A) Cytoplasmic and nuclear extracts, ranging from 15 to 40 Pdls, were analyzed for the expression of IKKα, IKKβ, NF-κB p50 and p65 subunits, IκBα and cyclin D1, or lamin B and β-actin. (B) Total cell lysates were analyzed for the expression of IKKα, IKKβ and cyclin D1 or β-actin by immunoblotting.
Fig. 2
Fig. 2
Generation of RasV12- and/or IKKβca-expressing IMR-90. (A) Infection scheme of IMR-90 with the replication defective recombinant retroviruses. (B) Total cell lysates extracted from uninfected IMR-90 and from HygroB- and/or Neo-resistant IMR-90 cells carrying either RasV12 and/or IKKβca or their corresponding control vectors were analyzed for the expression of Ha-RasV12 and IKKβca proteins or β-actin by immunoblotting.
Fig. 3
Fig. 3
IKKβca but not RasV12 activated canonical NF-κB signaling. (A) Total cell lysates extracted from uninfected IMR-90 and from HygroB- and/or Neo-resistant IMR-90 cells carrying either RasV12 and/or IKKβca or their corresponding control vectors were analyzed for the expression of phospho-IκBα (Ser32/36), IκBα or β-actin. (B) Proteins extracted from isolated nuclei of uninfected IMR-90 and from HygroB- and/or Neo-resistant IMR-90 cells carrying either RasV12 and/or IKKβca or their corresponding control vectors were analyzed for the expression of p50, p65 and IκBα, and lamin B by immunoblotting. (C) The relative expression levels of several canonical NF-κB target genes (IκBα, IL-6 and MCP-1/CCL2) were determined by SYBR green real-time RT-PCR in IMR-90 Neo, IMR-90 IKKβca and in IMR-90 cells stimulated with 100 ng/ml TNFα for 2 h. Fold change values are relative to empty vector control (IMR-90 Neo) cells grown under the same conditions. Results shown are representative of several experiments with variation being no more than 5-10%.
Fig. 4
Fig. 4
Analysis of growth properties of RasV12- and/or IKKβca-expressing IMR-90 fibroblasts. (A) HygroB- and/or Neo-resistant IMR-90 fibroblasts expressing either RasV12 and/or IKKβca or their corresponding control vectors were plated into 24-multiwell plates and counted every two days. The experiment was performed twice in duplicates and growth curves were constructed. (B) Flow cytometric analysis of all the different IMR-90 at P25. IMR-90 RasV12 at P18 and senescent IMR-90 at P42 fibroblasts were included in the analysis. The percentages of cells in corresponding phases of the cell cycle are indicated.
Fig. 5
Fig. 5
Morphologies and SA-β-Gal expression in RasV12- and/or IKKβca-expressing IMR-90. Morphologies and SA-β-Gal staining, as a marker for cellular senescence, of senescent IMR-90 (P39) fibroblasts and uninfected or HygroB- and/or Neo-resistant IMR-90 expressing either RasV12 and/or IKKβca or their corresponding control vectors.
Fig. 6
Fig. 6
Analysis of cell cycle regulatory proteins in RasV12- and/or IKKβca-expressing IMR-90 fibroblasts. (A) Total cell lysates extracted from normal IMR-90 and from HygroB- and/or Neo-resistant IMR-90 expressing either RasV12 and/or IKKβca or their corresponding control vectors were analyzed for the expression of selected cell cycle regulatory proteins or β-actin by immunoblotting. (B) Time course of expression of cyclin D1 and p21Cip1/Waf1 in sub-confluent proliferating cultures of IMR-90 Neo and IMR-90 IKKβca fibroblasts following serum stimulation of the cells for 0 - 24 h.
Fig. 7
Fig. 7
Analysis of proteins involved in DNA damage checkpoint response in RasV12- and/or IKKβca-expressing IMR-90 fibroblasts. Total cell lysates extracted from HygroB- and/or Neo-resistant IMR-90 expressing either RasV12 and/or IKKβca or their corresponding control vectors were analyzed for the expression of phospho-Chk2 (Thr68), total Chk2, phospho-p53 (Ser15 and Ser20) and total p53 or β-actin by immunoblotting.

References

    1. Adler AS, Sinha S, Kawahara TLA, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev. 2007;21:3244–3257. - PMC - PubMed
    1. Aggarwal BB, Totpal K, La Pushin R, Chaturvedi MM, Pereira-Smith OM, Smith JR. Diminished responsiveness of senescent normal human fibroblasts to TNF-dependent proliferation and interleukin production is not due to its effect on the receptors or on the activation of a nuclear factor NF-κB. Exp. Cell Res. 1995;218:381–388. - PubMed
    1. Ahmed KM, Li JJ. NF-κB-mediated adaptive resistance to ionizing radiation. Free Radic. Biol. Med. 2008;44:1–13. - PMC - PubMed
    1. Araki K, Kawauchi K, Tanaka N. IKK/NF-κB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors. Onogene. 2008;27:5696–5705. - PubMed
    1. Bartek J, Lucas J. Balancing Life-or-Death decisions. Science. 2006;314:261–262. - PubMed

Publication types

MeSH terms